Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity-Reference-Cited by-同舟云学术

Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity

Published:2008-05-01 Issue:11 Volume:51 Page:3061-3064
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chackalamannil Samuel¹,Wang Yuguang¹,Greenlee William J.¹,Hu Zhiyong¹,Xia Yan¹,Ahn Ho-Sam¹,Boykow George¹,Hsieh Yunsheng¹,Palamanda Jairam¹,Agans-Fantuzzi Jacqueline¹,Kurowski Stan¹,Graziano Michael¹,Chintala Madhu¹

Affiliation:

1. Schering-Plough Research Institute, 2015 Galloping Hill Rd, Kenilworth, New Jersey 07033

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm800180e

Reference36 articles.

1. World Health Organization. Atlas of Heart Disease and Stroke;World Health Organization:Geneva, Switzerland, 2004.

2. National Center for Health Statistics. Health, United States, 2005 with Chartbook on Trends in the Health of Americans;National Center for Health Statistics:Hyattsville, MD, 2005, p178.

3. Inflammation, Atherosclerosis, and Coronary Artery Disease

4. Macrophage Activation in Atherosclerosis: Pathogenesis and Pharmacology of Plaque Rupture

Cited by 246 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing Modulators of Protease-activated Receptors with a Calcium Mobilization Assay Using a Plate Reader;Journal of Visualized Experiments;2024-05-24

2. Discovery of 2,3-Dihydro[1,4]dioxino[2,3-g]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency;Journal of Medicinal Chemistry;2024-03-29

3. GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease;European Heart Journal - Cardiovascular Pharmacotherapy;2024-03-07

4. S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis;Cell;2023-11

5. Protease-Activated Receptor 1–Mediated Damage of Podocytes in Diabetic Nephropathy;Diabetes;2023-09-18